James Rolke - Oct 29, 2025 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Chief Executive Officer, Director
Signature
/s/ J.P. Galda, as attorney-in-fact for James Rolke
Stock symbol
REVB
Transactions as of
Oct 29, 2025
Transactions value $
$499,986
Form type
4
Date filed
10/31/2025, 12:58 PM
Previous filing
Feb 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rolke James Chief Executive Officer, Director C/O REVELATION BIOSCIENCES, INC., 4660 LA JOLLA VILLAGE DR., SUITE 100, SAN DIEGO /s/ J.P. Galda, as attorney-in-fact for James Rolke 2025-10-30 0001693858

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Award $500K +391K +3888.25% $1.28 401K Oct 29, 2025 Direct F1
holding REVB Common Stock 10K Oct 29, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests quarterly over one year from the grant date.